CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Atlantic Medical Imaging

Atlantic Medical Imaging is a quality-driven medical imaging practice committed to clinical excellence by providing innovative service and compassionate care that exceeds expectations.

Carstens

For more than 130 years, Carstens has focused on the specific and evolving needs of healthcare professionals - providing revolutionary solutions that transform clinical environments, enhance patient experiences and positively impact results. The first to bring patient information to the point of care, we have always been passionate about connecting with the human side of healthcare. Today, we continue to lead the industry with our inventive product development - bringing new solutions to new demands for more efficient, productive and interactive care. Carstens - connecting with the human side of healthcare.

Discovery Alliance

Discovery Alliance is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ambulatory Care Affiliates

Ambulatory Care Affiliates, Ltd. is a New Albany, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synaptic Science

Synaptic Science is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.